PP_1170x120_10-25-21

Medicis Pharmaceutical Corporation’s Solodyn 55 mg

Lupin launches generic minocycline hydrochloride ER tablets

Lupin launches generic minocycline hydrochloride ER tablets

BALTIMORE — Lupin announced the launch of minocycline hydrochloride extended-release tablets USP 55mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s minocycline hydrochloride ER tablets USP 55mg is a generic version of Medicis Pharmaceutical Corporation’s Solodyn 55 mg. It is indicated to treat only inflammatory lesions of non-nodular

Adheris Health